Murphy Sean
SEC insider (Form 3/4/5 filer). CIK 0001685042. Chief Manuf, Strategy&Bus Dev. at TriSalus Life Sciences, Inc. (TLSI). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2025. Located in WESTMINSTER, CO.
Companies Murphy Sean has filed insider reports for
- TriSalus Life Sciences, Inc. (TLSI): Director, Officer, Chief Manuf, Strategy&Bus Dev.
Murphy Sean
CIK: 0001685042
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TriSalus Life Sciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 12, 2025TLSI
TriSalus Life Sciences, Inc.
AwardDirectDirector Stock Option (right to buy)
15K shares- - May 19, 2025TLSI
TriSalus Life Sciences, Inc.
AwardDirect44.9K shares at avg. $5.18$232K - Feb 18, 2025TLSI
TriSalus Life Sciences, Inc.
AwardDirect15.8K shares- - Jan 28, 2025TLSI
TriSalus Life Sciences, Inc.
PurchaseIndirect15K shares at avg. $5.17$78K - Jan 27, 2025TLSI
TriSalus Life Sciences, Inc.
AwardDirect12.5K shares- - Jan 27, 2025TLSI
TriSalus Life Sciences, Inc.
PurchaseIndirect15K shares at avg. $5.31$80K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2025 | TLSI TriSalus Life Sciences, Inc. | Award Director Stock Option (right to buy) | 15,000 | - | - | Direct |
| May 19, 2025 | TLSI TriSalus Life Sciences, Inc. | Award | 44,884 | $5.18 | $232,499 | Direct |
| Feb 18, 2025 | TLSI TriSalus Life Sciences, Inc. | Award | 15,817 | - | - | Direct |
| Jan 28, 2025 | TLSI TriSalus Life Sciences, Inc. | Purchase | 15,000 | $5.17 | $77,550 | Indirect |
| Jan 27, 2025 | TLSI TriSalus Life Sciences, Inc. | Award | 12,500 | - | $0 | Direct |
| Jan 27, 2025 | TLSI TriSalus Life Sciences, Inc. | Purchase | 15,000 | $5.31 | $79,650 | Indirect |
1-6 of 6 transactions